Clinilabs is a global, full-service Contract Research Organization (CRO) that specializes in the development of drugs, devices, and technologies specifically for central nervous system (CNS) disorders. The company offers a comprehensive range of services that span from early development phases, including first-in-human trials, to Phase 3 clinical trials. Clinilabs focuses on addressing significant unmet needs in the CNS field, which encompasses neurological disorders, substance use disorders, rare CNS disorders, and mental health disorders. Their approach combines extensive experience, scientific knowledge, and operational expertise to facilitate the development of new therapies aimed at improving patient outcomes.

In addition to their clinical trial management services, Clinilabs employs advanced data sciences and core lab services, including clinical data management and biostatistics. They utilize electronic case report forms and have a robust programming and database architecture to support their clinical research efforts. The company also emphasizes decentralized trials, leveraging technology to enhance patient engagement and streamline the research process. Through these innovative methodologies, Clinilabs aims to bring new therapies to patients while maintaining a commitment to accountability and integrity in their operations.

United States

Clinilabs Drug Development Corporation is a contract research organization (CRO) that provides clinical drug development services to industry.  We are experts in CNS drug development.  

Clinilabs provides first-in-human through end of phase 3 services, with a global core laboratory.  It is an alternative to large CROs providing a full spectrum of offerings to meet the needs of our customers world wide.

Since 2000, Clinilabs has completed more than 675 clinical trials, and has worked for 15 of the top 20 pharma companies in the world, to contribute to 19 successful new drug applications (NDAs).

Clinilabs

Company Details